CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 60 filers reported holding CYTOSORBENTS CORP in Q1 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $20 | -99.9% | 1,687 | +16.0% | 0.00% | – |
Q3 2022 | $17,000 | 0.0% | 1,454 | 0.0% | 0.00% | -100.0% |
Q2 2022 | $17,000 | 0.0% | 1,454 | 0.0% | 0.00% | – |
Q1 2022 | $17,000 | – | 1,454 | – | 0.00% | – |
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2020 | $16,000 | 0.0% | 1,967 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $16,000 | – | 1,967 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q3 2018 | $6,000 | -82.9% | 430 | -92.3% | 0.00% | -100.0% |
Q3 2017 | $35,000 | +45.8% | 5,600 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $24,000 | -4.0% | 5,600 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $25,000 | -19.4% | 5,600 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $31,000 | -13.9% | 5,600 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $36,000 | +44.0% | 5,600 | 0.0% | 0.00% | +100.0% |
Q2 2016 | $25,000 | -19.4% | 5,600 | 0.0% | 0.00% | -50.0% |
Q4 2015 | $31,000 | – | 5,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 964,141 | $7,829,000 | 1.90% |
Skylands Capital, LLC | 1,837,541 | $14,921,000 | 1.84% |
CM Management, LLC | 175,000 | $1,421,000 | 1.06% |
Soleus Capital Management, L.P. | 800,000 | $6,496,000 | 1.01% |
Avenir Corp | 1,395,385 | $11,331,000 | 0.95% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,502,000 | 0.55% |
Winning Points Advisors, LLC | 86,200 | $701,000 | 0.51% |
Granahan Investment Management | 1,154,561 | $9,375,000 | 0.18% |
SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,987,000 | 0.16% |
Redmile Group, LLC | 1,044,434 | $8,481,000 | 0.15% |